8th Critical Care Clinical Trialists
3CT workshop
June 1-2, 2026 | Washington, DC
Welcome to the 3CT Workshop!
We are pleased to introduce you to 8th edition of the Critical Care Clinical Trialists (3CT) Workshop, which will take place on June 1 & 2, 2026, at the Embassy of France in Washington, DC.
The 3CT Workshop aims to foster an international exchange of ideas where attendees will brainstorm on trial design, conduct, ethics and data interpretation in the critical care area. The sessions will cover domains including drugs, devices, and biomarkers in the field of intensive care.
Following the template of the CVCT Forum, the Critical Care Clinical Trialists (3CT) workshop is a high-level think-tank, with an exceptional expert faculty. It involves a limited number of attendees and includes distinguished intensivists, pulmonologists, cardiologists, emergency physicians, clinical trialists, principal investigators, patient representatives and statisticians from academia, R&D pharma, NIH, EMA, FDA and PMDA.
We are pleased to announce that for the 7th year running, the proceedings from last year’s Workshop have been accepted for publication in world leading medical journals.
The 3CT Organizing committee
3CT 2025 MEETING REPLAYS
Now available to watch!
Latest from 3CT
NEW ARTICLE OUT NOW : Optimising trial design for cardiogenic shock: insights from the sixth Critical Care Clinical Trialists Workshop (The Lancet Respiratory Journal)
--
NEW ARTICLE OUT NOW : Optimising trial design for cardiogenic shock: insights from the sixth Critical Care Clinical Trialists Workshop (The Lancet Respiratory Journal) --
Feedbacks from our participants
“The possibility to have an informal discussions with regulators from the field is absolutely valuable. Also hearing about ongoing clinical trials in the field, their endpoints, struggles and progress is helpful.”
“The 3CT Workshop is a unique experience of inspiring brainstorming with KOLs in the trial world”
“This congress [...] is now the key event in the field of cardiogenic shock. It gives you insights in novel treatment strategies and ongoing trials investigating potential targets in acute cardiac care. It helps you to reflect critically on the current evidence, the strengths and limitations of recent trials, and it gives insights in clinical trial development and refinement. It provides you with a broad professional network and makes interaction possible with professionals over the globe.”
“This congress [...] is now the key event in the field of cardiogenic shock.”
PARTNERSHIP WITH THE FDA
Rooted in regulatory engagement — with direct FDA input and presence.
Taking place in…
Washington D.C.
home of the FDA and epicenter of regulatory science.
